# 바이오스페이스 일일 뉴스 리포트 - 2025년 10월 31일


## 주요 헤드라인

1. **Lilly Walks Pricing Tightrope With Upcoming Weight Loss Pill Orforglipron (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-walks-pricing-tightrope-with-upcoming-weight-loss-pill-orforglipron>

2. **Lilly Walks Pricing Tightrope With Upcoming Weight Loss Pill Orforglipron (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-walks-pricing-tightrope-with-upcoming-weight-loss-pill-orforglipron>

3. **Merck Vaccine Sales Drop as US Declines Strike Another Pharma (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/merck-vaccine-sales-drop-as-us-declines-strike-another-pharma>

4. **Merck Vaccine Sales Drop as US Declines Strike Another Pharma (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/merck-vaccine-sales-drop-as-us-declines-strike-another-pharma>

5. **BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/bms-battles-deeply-ingrained-prescribing-habits-in-schizophrenia-as-cobenfy-misses-q3-estimates>

6. **As Biogen Nears Presymptomatic Alzheimer’s Readout for Leqembi, Can Doctors Be Convinced? (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/as-biogen-nears-presymptomatic-alzheimers-readout-for-leqembi-can-doctors-be-convinced>

7. **Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/zepbound-topples-sales-king-keytruda-as-lilly-reports-54-yoy-revenue-rise-for-q3>


---
*2025년 10월 31일 바이오스페이스 뉴스 피드에서 생성된 리포트*